| Year |
Citation |
Score |
| 2023 |
Talvio K, Wagner VA, Minkeviciene R, Kirkwood JS, Kulinich AO, Umemori J, Bhatia A, Hur M, Käkelä R, Ethell IM, Castrén ML. An iPSC-derived astrocyte model of fragile X syndrome exhibits dysregulated cholesterol homeostasis. Communications Biology. 6: 789. PMID 37516746 DOI: 10.1038/s42003-023-05147-9 |
0.604 |
|
| 2022 |
Dennys C, Baggio C, Rodrigo R, Roussel F, Kulinich A, Heintzman S, Fox A, Kolb SJ, Shaw PJ, Ethell IM, Pellecchia M, Meyer KC. EphA4 targeting agents protect motor neurons from cell death induced by amyotrophic lateral sclerosis -astrocytes. Iscience. 25: 104877. PMID 36034213 DOI: 10.1016/j.isci.2022.104877 |
0.662 |
|
| 2021 |
Rais M, Lovelace JW, Shuai XS, Woodard W, Bishay S, Estrada L, Sharma AR, Nguy A, Kulinich A, Pirbhoy PS, Palacios AR, Nelson DL, Razak KA, Ethell IM. Functional consequences of postnatal interventions in a mouse model of Fragile X syndrome. Neurobiology of Disease. 162: 105577. PMID 34871737 DOI: 10.1016/j.nbd.2021.105577 |
0.531 |
|
| 2021 |
Baggio C, Kulinich A, Dennys CN, Rodrigo R, Meyer K, Ethell I, Pellecchia M. NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands. Journal of Medicinal Chemistry. PMID 34293864 DOI: 10.1021/acs.jmedchem.1c00608 |
0.638 |
|
| 2019 |
Kulinich AO, Reinhard SM, Rais M, Lovelace JW, Scott V, Binder DK, Razak KA, Ethell IM. Beneficial effects of sound exposure on auditory cortex development in a mouse model of Fragile X Syndrome. Neurobiology of Disease. 104622. PMID 31698054 DOI: 10.1016/J.Nbd.2019.104622 |
0.68 |
|
| 2017 |
Wu B, De SK, Kulinich A, Salem AF, Koeppen J, Wang R, Barile E, Wang S, Zhang D, Ethell I, Pellecchia M. Potent and Selective EphA4 Agonists for the Treatment of ALS. Cell Chemical Biology. PMID 28196613 DOI: 10.1016/J.Chembiol.2017.01.006 |
0.596 |
|
| Show low-probability matches. |